Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Deferred Taxes Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Equity Investments Gains from Equity Investments Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Growth Metrics

Cresco Labs (CRLBF) Non-cash Items (2023 - 2024)

Cresco Labs filings provide 2 years of Non-cash Items readings, the most recent being $24000.0 for Q3 2024.

On a quarterly basis, Non-cash Items fell 92.52% to $24000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $24000.0, a 92.52% decrease, with the full-year FY2023 number at $209000.0, changed N/A from a year prior.
Non-cash Items hit $24000.0 in Q3 2024 for Cresco Labs, roughly flat from $24000.0 in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $321000.0 in Q2 2023 to a low of $24000.0 in Q1 2024.